Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.930
-0.000 (-0.02%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Jasper Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -75.8 | -71.27 | -64.47 | -37.69 | -30.64 | |
| Depreciation & Amortization | 1.06 | 1.37 | 1.11 | 0.98 | 0.38 | |
| Asset Writedown & Restructuring Costs | 1.11 | - | - | - | - | |
| Stock-Based Compensation | 6.71 | 6.62 | 5.21 | 4.09 | 1.05 | |
| Other Operating Activities | -5.32 | 0.49 | 0.98 | -12.59 | -6.09 | |
| Change in Accounts Receivable | - | - | 0.66 | -0.66 | 0.6 | |
| Change in Accounts Payable | 2.19 | -0.12 | 2.38 | -2.15 | 2.94 | |
| Change in Other Net Operating Assets | -7.12 | 0.31 | 2.06 | 2.17 | -1.92 | |
| Operating Cash Flow | -77.16 | -62.6 | -52.07 | -45.86 | -33.68 | |
| Capital Expenditures | -0.01 | -0.55 | -0.27 | -0.58 | -2.43 | |
| Sale of Property, Plant & Equipment | 0.01 | 0.02 | - | - | - | |
| Investing Cash Flow | 0.01 | -0.53 | -0.27 | -0.58 | -2.43 | |
| Issuance of Common Stock | 34.21 | 47.88 | 101.93 | 0.06 | 0.24 | |
| Repurchase of Common Stock | - | - | -0.96 | - | - | |
| Other Financing Activities | - | - | - | - | 89.98 | |
| Financing Cash Flow | 34.21 | 47.88 | 100.97 | 0.06 | 100.97 | |
| Net Cash Flow | -42.95 | -15.25 | 48.64 | -46.38 | 64.86 | |
| Free Cash Flow | -77.17 | -63.15 | -52.33 | -46.43 | -36.11 | |
| Free Cash Flow Per Share | -4.03 | -4.33 | -5.01 | -12.73 | -31.69 | |
| Levered Free Cash Flow | -47.19 | -39.59 | -30.35 | -29.17 | -22.8 | |
| Unlevered Free Cash Flow | -47.19 | -39.59 | -30.35 | -29.17 | -22.8 | |
| Change in Working Capital | -4.92 | 0.18 | 5.1 | -0.65 | 1.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.